References
- Preskorn S H. Pharmacokinetics of psychotropic agents: why and how they are relevant to treatment. J Clin Psychiatry 1993; 54: 3–7, (suppl)
- Greenblatt D J. Benzodiazepine hypnotics: sorting the pharmacokinetic facts. J Clin Psychiatry 1991; 52: 4–10, (9 suppl)
- Ciraulo D A, Shader R I, Greenblatt D J. SSRI drug-drug interactions. Drug interactions in psychiatry. 2nd ed., D A Ciraulo, R I Shader, D J Greenblatt, W Creelman. Williams & Wilkins, Baltimore 1995; 64–89
- Van Ameringen M, Mancini C. Adverse effects of switching from fluoxetine to desipramine [Letter]. Can J Psychiatry 1992; 37: 278
- Kreider M S, Bushnell W D, Oakes R, Wheadon D E. A doubleblind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period. J Clin Psychiatry 1995; 56: 142–5
- Nestler E J, Duman R S. Intracellular messenger pathways as mediators of neural plasticity. Psychopharmacology: the fourth generation of progress, F E Bloom, D J Kupfer. Raven, New York 1995; 695–704
- Van Praag H. “Make-believes” in psychiatry, or the perils of progress. Brunner/Mazel, New York 1992
- Mavissakalian M R. Phenomenology of panic attacks: responsiveness of individual symptoms to imipramine. J Clin Psychopharmacol 1996; 16: 233–7
- Feighner J P, Boyer W F. Paroxetine in the treatment of depression: a comparison with imipramine and placebo. J Clin Psychiatry 1992; 53: 44–7, (2 suppl)
- Sherman C. Chronic depression delays response to drug therapy. Clin Psychiatry News 1996; 24(9)20
- Albert R, Ebert D. Full efficacy of SSRI treatment in refractory dysthymia is achieved only after 16 weeks [Letter]. J Clin Psychiatry 1996; 57: 176
- Quitkin F M, McGrath P J, Stewart J W, Ocepek-Welikson K, Taylor B P, Nunes E, et al. Chronological milestones to guide drug change: when should clinicians switch antidepressants?. Arch Gen Psychiatry 1996; 53: 785–92
- Dubovsky S. When to switch antidepressants. J Watch Psychiatry 1996; 2: 86
- Breier A, Wolkowitz O M, Doran A R, Roy A, Boronow J, Hommer D W, et al. Neuroleptic responsivity of negative and positive symptoms in schizophrenia. Am J Psychiatry 1987; 144: 1549–55
- Baldessarini R J, Tondo L, Faedda G L, Suppes T R, Floris G., Rudas N. Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. J Clin Psychiatry 1996; 57: 441–8
- Malhotra S, Santosh P J. Loading dose imipramine—new approach to pharmacotherapy of melancholic depression. J Psychiatr Res 1996; 30: 51–8
- Nelson J C, Mazure C M, Bowers M B, Jr, Jatlow P I. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry 1991; 48: 303–7
- Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 1994; 51: 248–51
- Allan E R, Alpert M, Sison C E, Citrome L, Laury G, Berman I. Adjunctive nadolol in the treatment of acutely aggressive schizophrenic patients. J Clin Psychiatry 1996; 57: 455–9
- Pies R. Festina lente: tincture of time in psychopharmacology. Psychiatr Times 1994; 11: 11